Salivary Biomarkers for Alzheimer’s Disease: A Systematic Review with Meta-Analysis

Author:

Nijakowski Kacper1ORCID,Owecki Wojciech2,Jankowski Jakub2ORCID,Surdacka Anna1ORCID

Affiliation:

1. Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland

2. Student’s Scientific Group in Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland

Abstract

Alzheimer’s Disease (AD) is the most common neurodegenerative disease which manifests with progressive cognitive impairment, leading to dementia. Considering the noninvasive collection of saliva, we designed the systematic review to answer the question “Are salivary biomarkers reliable for the diagnosis of Alzheimer’s Disease?” Following the inclusion and exclusion criteria, 30 studies were included in this systematic review (according to the PRISMA statement guidelines). Potential biomarkers include mainly proteins, metabolites and even miRNAs. Based on meta-analysis, in AD patients, salivary levels of beta-amyloid42 and p-tau levels were significantly increased, and t-tau and lactoferrin were decreased at borderline statistical significance. However, according to pooled AUC, lactoferrin and beta-amyloid42 showed a significant predictive value for salivary-based AD diagnosis. In conclusion, potential markers such as beta-amyloid42, tau and lactoferrin can be detected in the saliva of AD patients, which could reliably support the early diagnosis of this neurodegenerative disease.

Publisher

MDPI AG

Reference95 articles.

1. Molecular and Cellular Mechanisms Underlying the Pathogenesis of Alzheimer’s Disease;Guo;Mol. Neurodegener.,2020

2. The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention;Zhang;J. Prev. Alzheimers Dis.,2021

3. Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021;Porsteinsson;J. Prev. Alzheimers Dis.,2021

4. Alzheimer’s Disease;Lane;Eur. J. Neurol.,2018

5. New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer’s Disease;Farias;J. Alzheimers Dis.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3